Skip to main content
background gradient

Volume 12Issue 9

Editorial

Open Access
For what it's worth: the complex area of medicine value assessment
  • Sreeram V Ramagopalan,
  • Catrin Treharne,
  • Jonathan Pearson-Stuttard, and
  • Vivek Subbiah
e230120
Published Online:29 July 2023

Plain Language Summary of Publication

Open Access
Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study
  • David Staskin,
  • Jeffrey Frankel,
  • Steven G Gregg,
  • Susann Varano, and
  • Janet Owens-Grillo
e230043
Published Online:10 August 2023
Preview Abstract
Open Access
Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
  • Jeffrey Frankel,
  • David Staskin,
  • Susann Varano,
  • Diane K Newman,
  • Steven G Gregg, and
  • Janet Owens-Grillo
e230049
Published Online:10 August 2023
Preview Abstract

Research Article

Open Access
Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome
  • Teri J Mauch,
  • Michael R Chladek,
  • Spero Cataland,
  • Shruti Chaturvedi,
  • Bradley P Dixon,
  • Katherine Garlo,
  • Christoph Gasteyger,
  • Anuja Java,
  • Jorge Leguizamo,
  • Lucy Lloyd-Price,
  • Tan P Pham,
  • Tara Symonds,
  • Ioannis Tomazos, and
  • Yan Wang
e230036
Published Online:29 July 2023
Preview Abstract
Open Access
Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
  • Aaron T Gerds,
  • Claudia Castro,
  • Frank Snopek,
  • Megan M Flynn,
  • Alexandra G Ellis,
  • Meredith Manning, and
  • Ray Urbanski
e230066
Published Online:2 August 2023
Preview Abstract
Open Access
Cost–consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada
  • Virender Bhan,
  • Fraser Clift,
  • Moogeh Baharnoori,
  • Kimberly Thomas,
  • Barkha P Patel,
  • François Blanchette,
  • Nicholas Adlard,
  • Umakanth Vudumula,
  • Kapil Gudala,
  • Nikkita Dutta,
  • Daniel Grima,
  • Soukaïna Mouallif, and
  • Fatine Farhane
e220175
Published Online:22 August 2023
Preview Abstract
Open Access
Real-world evidence of eteplirsen treatment effects in patients with Duchenne muscular dystrophy in the USA
  • Joel Iff,
  • Yi Zhong,
  • Edward Tuttle,
  • Deepshekhar Gupta,
  • Xander Paul, and
  • Erik Henricson
e230086
Published Online:23 August 2023
Preview Abstract
Open Access
QDOT MICRO™ versus THERMOCOOL® SMARTTOUCH™ and THERMOCOOL SMARTTOUCH® Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation
  • Jose Osorio,
  • Sonia Maccioni,
  • Reecha Sharma,
  • Leena Patel,
  • Paul Spin, and
  • Andrea Natale
e230005
Published Online:16 August 2023
Preview Abstract